Journey Medical Corp (DERM)
5.32
-0.85
(-13.78%)
USD |
NASDAQ |
Nov 04, 16:00
5.32
0.00 (0.00%)
After-Hours: 20:00
Journey Medical Research and Development Expense (TTM): 12.53M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 12.53M |
| March 31, 2024 | 13.39M |
| December 31, 2023 | 7.541M |
| September 30, 2023 | 10.29M |
| June 30, 2023 | 10.88M |
| March 31, 2023 | 11.71M |
| December 31, 2022 | 10.94M |
| Date | Value |
|---|---|
| September 30, 2022 | 8.679M |
| June 30, 2022 | 6.661M |
| March 31, 2022 | 17.82M |
| December 31, 2021 | 16.56M |
| September 30, 2021 | 14.57M |
| June 30, 2021 | 13.77M |
| March 31, 2021 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
Mar 2021
17.82M
Maximum
Mar 2022
11.10M
Average
11.33M
Median
Research and Development Expense (TTM) Benchmarks
| Fortress Biotech Inc | 71.93M |
| Checkpoint Therapeutics Inc | 26.77M |
| Avenue Therapeutics Inc | 5.642M |
| Eton Pharmaceuticals Inc | 5.283M |
| Elutia Inc | 4.113M |